Wei Ao

Dr. Wei Ao

orcid

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications

18 July 2024 in Journal of Biomedical Optics
Verified
Journal Article
Open access
PDF file
BWBo WANG
Bo WANG
CZChi-Peng Zhou
Chi-Peng Zhou
WAWei Ao
Wei Ao
SCShao-Jun Cai
Shao-Jun Cai
ZGZhi-Wen Ge
Zhi-Wen Ge
WZWenxin Zhao
Wenxin Zhao
Parathyroid glands (PGs) are small endocrine organs that regulate calcium homeostasis by secreting parathyroid hormone (PTH) in response to changes in serum calcium levels. PGs are usually located on the posterior surface of the thyroid gland, but their position and number can vary widely. The normal number of PGs is four, but some people may have three or more and occasionally up to eight or more.1 Identifying and preserving PGs during thyroid surgery is crucial to prevent postoperative hypoparathyroidism, which can cause hypocalcemia, tetany, and other complications.2

21 November 2025 in Diagnostics
Verified
Journal Article
Open access
PDF file
WAWei Ao
Wei Ao
SCShuqian Chen
Shuqian Chen
TLTenghong Liu
Tenghong Liu
BWBo WANG
Bo WANG
WZWenxin Zhao
Wenxin Zhao
Background: Adolescents and young adults (AYA) with papillary thyroid carcinoma (PTC) often present with more extensive cervical lymph node metastasis (LNM) than older adults (AD). We aimed to identify age-associated molecular and immune features that might explain this phenotype and to explore potential translational implications for managing aggressive AYA PTC. Methods: We analyzed clinical and transcriptomic data from 501 PTC cases in The Cancer Genome Atlas (TCGA), stratified as AYA (<30 years, n = 64) and AD (≥30 years, n = 437). An institutional RNA-seq cohort (n = 13; 7 AYA, 6 AD) was used to screen for differentially expressed genes (DEGs). DEGs were defined by p ≤ 0.05 and |log2 fold change| ≥ 1. Intersection with invasion- and dissemination-related gene sets yielded a final age-related DEG list. Functional enrichment (GO/KEGG via DAVID), PPI network analysis (STRING, Cytoscape/cytoHubba), and immune deconvolution (CIBERSORT LM22) were performed. Protein-level validation was carried out by immunohistochemistry (IHC) in an independent cohort (n = 56; 28 AYA, 28 AD). Statistical comparisons used chi-square/Fisher’s exact tests for categorical variables, t-tests or nonparametric tests for continuous variables, and EdgeR with FDR correction for transcriptomic analyses. Results: In TCGA, LNM was more frequent in AYA than in AD (62.1% vs. 47.8%, p = 0.031). From intersected analyses, we identified 239 core DEGs distinguishing highly invasive, age-related tumors. Key upregulated genes in AYA included CXCR4, OPCML and S100A2; downregulated genes included ATP1A3, CHL1, HLA-DRA and IL-1β. Enriched pathways involved extracellular matrix organization, cell adhesion, calcium signaling and canonical oncogenic cascades (PI3K-Akt, MAPK, Wnt, Ras). Immune deconvolution showed reduced naïve B cells, M1 and M2 macrophages and resting mast cells and an increased proportion of M0 macrophages in AYA tumors. IHC validated differential protein expression for seven markers. Collectively, the data indicate an immune-suppressed, immune-excluded microenvironment in AYA PTC. Conclusions: AYA PTC exhibits distinct molecular and immune features that may underlie its propensity for lymphatic dissemination. These findings support evaluation of translational strategies, such as CXCR4 inhibition, restoration of antigen presentation, and macrophage reprogramming, to convert “cold” tumors into immune-permissive lesions. Validation in larger, prospective, multicenter cohorts is required.